Our nanorobots combine navigation, catalysis and bactericide capacity to carry antimicrobial charges to specific sites of infection.
Xavier Arqué, first co-author of the work (IBEC)
Samuel Sánchez, principal investigator at IBEC appears in the media for his co-led study with César de la Fuente-Núñez of the University of Pennsylvania, USA, on the development of nanorobots to fight bacterial infections.
Nanorobots, which attack bacteria at the site of infection, would also prevent one of the major problems facing medicine today: antibiotic resistance.
You can read all the impacts here:
